Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011095 |
---|---|
Receipt number | R000012669 |
Scientific Title | A Multicenter phase II study of Carboplatin/Pemetrexed/Bevacizumab in First-Line Treatment of Elderly Patients with Advanced Non-squamous and Non-small Cell Lung cancer |
Date of disclosure of the study information | 2013/07/02 |
Last modified on | 2018/07/06 14:53:24 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/07/02 15:50:42 | ||
2 | Update | 2014/01/07 08:20:22 | Last name of lead principal investigator Last name of lead principal investigator Division name TEL Last name of contact person Last name of contact person Organization Division name Address TEL Name of person sending information Division name Organization1 Email1 |
|
3 | Update | 2018/07/06 14:49:48 | Recruitment status Publication of results |
|
4 | Update | 2018/07/06 14:53:24 | Name of primary person or sponsor Organization Institutions |